MLTX,MoonLake Immunotherapeutics | Healthcare

Healthcare

MLTX

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

MoonLake ImmunotherapeuticsMLTX

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies.

It is developing Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases.

The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or axial spondyloarthritis.

MoonLake Immunotherapeutics was incorporated in 2021 and is headquartered in Zug, Switzerland.

Latest News >

Fragrance and flavour maker Givaudan tops Q3 sales forecast on strong demand

Oct 10, 2024

(Reuters) -Swiss fragrance and flavour maker Givaudan reported third-quarter sales above analysts' expectations on Thursday, driven by sustained high demand across its markets. Givaudan's sales rose 10.2% to 1.91 million Swiss francs ($2.22 million) on a reported basis in the July-September period, ahead of analysts' average forecast of 1.86 billion francs in a poll compiled by the company. While the...

INDIA STOCKS-Indian shares edge higher; investors await TCS earnings, US CPI

Oct 10, 2024

(Updates at 10:22 a.m. IST) By Bharath Rajeswaran Oct 10 (Reuters) - Indian shares rose on Thursday as minutes from the Federal Reserve's latest policy meeting reinforced hopes of more rate cuts in the United States, which could likely trigger more inflows into emerging markets. The Nifty 50 index was up 0.44% at 25,090.8 points as of 10:22 a.m. IST,...

Analysis-Risks from potentially contested US election appear on market's radar

Oct 10, 2024

NEW YORK (Reuters) - A tight U.S. presidential race is leading some investors to brace for an unclear or contested election result that could trip up this year's booming stock market rally. With less than a month before the election, polls and prediction markets show Democrat Kamala Harris and Republican Donald Trump in a virtual dead heat. Harris led Trump...

Swiss stocks - Factors to watch on October 10

Oct 10, 2024

ZURICH/GDANSK, Oct 10(Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: Givaudan Swiss fragrance and flavour maker Givaudan reported third-quarter sales above analysts' expectations on Thursday, driven by sustained high demand across its markets. KinderCare Partners Group-backed KinderCare Learning Companies ( KLC ) notched a market valuation of about $3.1 billion after its...